On October 6, 2017– Incyte Corporation (Nasdaq:INCY) and Cancer Support Community Delaware (CSCDE) reported the establishment of the Incyte Cancer Care Assistance Fund for Delaware which will provide emergency financial assistance for cancer patients, their caregivers and family members living in Delaware (Press release, Incyte, OCT 6, 2017, View Source;p=RssLanding&cat=news&id=2305148 [SID1234520802]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Through the Incyte Charitable Giving Foundation, Incyte has committed to providing a maximum of $100,000 each year to CSCDE over the next 5 years, beginning in 2018.
"We are very pleased to announce the creation of the Incyte Cancer Care Assistance Fund for Delaware with Cancer Support Community Delaware, an organization which, like Incyte, is dedicated to supporting patients with cancer and the local community," said Paula Swain, Executive Vice President of Human Resources and Chair of The Incyte Charitable Giving Foundation. "Today, as we celebrate the opening of our newly expanded headquarters in Wilmington, we reaffirm our commitment to Delaware and to the well-being of the communities we serve."
The fund will be administered by Cancer Support Community Delaware. Additional details about the Incyte Cancer Care Assistance Fund for Delaware will be made available in January 2018.
"Through the establishment of this fund, we aim to address the emergent needs that patients with cancer in Delaware face as they navigate their disease and its impact across all aspects of their lives," said Nicole Topkis Pickles, Executive Director of Cancer Support Community Delaware.